Your browser doesn't support javascript.
loading
Acceptability of human papillomavirus (HPV) self-sampling among never- and under-screened Indigenous and other minority women: a randomised three-arm community trial in Aotearoa New Zealand.
Brewer, Naomi; Bartholomew, Karen; Grant, Jane; Maxwell, Anna; McPherson, Georgina; Wihongi, Helen; Bromhead, Collette; Scott, Nina; Crengle, Sue; Foliaki, Sunia; Cunningham, Chris; Douwes, Jeroen; Potter, John D.
Afiliação
  • Brewer N; Research Centre for Hauora and Health, Massey University, PO Box 756, Wellington 6140, New Zealand.
  • Bartholomew K; Waitemata District Health Board (DHB) and Auckland DHB, Private Bag 93-503, Takapuna, Auckland 0740, New Zealand.
  • Grant J; Waitemata District Health Board (DHB) and Auckland DHB, Private Bag 93-503, Takapuna, Auckland 0740, New Zealand.
  • Maxwell A; Waitemata District Health Board (DHB) and Auckland DHB, Private Bag 93-503, Takapuna, Auckland 0740, New Zealand.
  • McPherson G; Waitemata District Health Board, Auckland, New Zealand.
  • Wihongi H; Waitemata District Health Board (DHB) and Auckland DHB, Private Bag 93-503, Takapuna, Auckland 0740, New Zealand.
  • Bromhead C; School of Health Sciences, Massey University, Wellington, New Zealand.
  • Scott N; University of Auckland, Waikato District Health Board, New Zealand.
  • Crengle S; Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.
  • Foliaki S; Research Centre for Hauora and Health, Massey University, PO Box 756, Wellington 6140, New Zealand.
  • Cunningham C; Research Centre for Hauora and Health, Massey University, PO Box 756, Wellington 6140, New Zealand.
  • Douwes J; Research Centre for Hauora and Health, Massey University, PO Box 756, Wellington 6140, New Zealand.
  • Potter JD; Research Centre for Hauora and Health, Massey University, PO Box 756, Wellington 6140, New Zealand.
Lancet Reg Health West Pac ; 16: 100265, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34590066
BACKGROUND: Internationally, self-sampling for human papillomavirus (HPV) has been shown to increase participation in cervical-cancer screening. In Aotearoa New Zealand, there are long-standing ethnic inequalities in cervical-cancer screening, incidence, and mortality, particularly for indigenous Maori women, as well as Pacific and Asian women. METHODS: We invited never- and markedly under-screened (≥5 years overdue) 30-69-year-old Maori, Pacific, and Asian women to participate in an open-label, three-arm, community-based, randomised controlled trial, with a nested sub-study. We aimed to assess whether two specific invitation methods for self-sampling improved screening participation over usual care among the least medically served populations. Women were individually randomised 3:3:1 to: clinic-based self-sampling (CLINIC - invited to take a self-sample at their usual general practice); home-based self-sampling (HOME - mailed a kit and invited to take a self-sample at home); and usual care (USUAL - invited to attend a clinic for collection of a standard cytology sample). Neither participants nor research staff could be blinded to the intervention. In a subset of general practices, women who did not participate within three months of invitation were opportunistically invited to take a self-sample, either next time they attended a clinic or by mail. FINDINGS: We randomised 3,553 women: 1,574 to CLINIC, 1,467 to HOME, and 512 to USUAL. Participation was highest in HOME (14.6% among Maori, 8.8% among Pacific, and 18.5% among Asian) with CLINIC (7.0%, 5.3% and 6.9%, respectively) and USUAL (2.0%, 1.7% and 4.5%, respectively) being lower. In fully adjusted models, participation was statistically significantly more likely in HOME than USUAL: Maori OR=9.7, (95%CI 3.0-31.5); Pacific OR=6.0 (1.8-19.5); and Asian OR=5.1 (2.4-10.9). There were no adverse outcomes reported. After three months, 2,780 non-responding women were invited to participate in a non-randomised, opportunistic, follow-on substudy. After 6 months,192 (6.9%) additional women had taken a self-sample. INTERPRETATION: Using recruitment methods that mimic usual practice, we provide critical evidence that self-sampling increases screening among the groups of women (never and under-screened) who experience the most barriers in Aotearoa New Zealand, although the absolute level of participation through this population approach was modest. Follow-up for most women was routine but a small proportion required intensive support. TRIAL REGISTRATION: ANZCTR Identifier: ACTRN12618000367246 (date registered 12/3/2018) https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=371741&isReview=true; UTN: U1111-1189-0531. FUNDING: Health Research Council of New Zealand (HRC 16/405). PROTOCOL: http://publichealth.massey.ac.nz/assets/Uploads/Study-protocol-V2.1Self-sampling-for-HPV-screening-a-community-trial.pdf.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article